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(SOADAS). Eleven papers were included in a critical review of the
instruments. Development histories and psychometric properties
were largely adequate though each instrument was lacking in
some aspect. Each instrument has its individual merits; the 8-item
DTSQ, 7-itemDTTQ and 6-item SOADAS offer brevity, while the
21-item Diab-MedSat offers a more detailed approach. The
DTTQ and SOADAS focus speciﬁcally on tablet treatment, while
the DTSQ and Diab-MedSat enable within-groups comparisons
when changing treatment from tablets to insulin. CONCLU-
SIONS: The DTSQ, the Diab-MedSat, the DTTQ and the
SOADAS have acceptable development histories and psychomet-
ric properties, though evidence for both could be strengthened in
certain areas to fulﬁl the FDA’s requirements. Given the differing
focus/length of each instrument, selection will also depend on
study objectives.
PDB56
IDENTIFYING FACTORSTHAT AFFECT PATIENTS’
WILLINGNESSTO PAY FOR INHALED INSULIN
Pinto SL1, Holiday-Goodman M2, Black CD2
1University of Toledo,Toledo, OH, USA, 2The University of Toledo,
Toledo, OH, USA
BACKGROUND: Diabetes is a common chronic condition
affecting several millions of people in the United States. Insulin
supplementation is essential for controlling diabetes. However,
not all patients are receptive to taking injectable insulin and are
therefore more likely to be noncompliant with therapy. Inhaled
insulin is as efﬁcacious as subcutaneous insulin, but patients’
willingness to pay for inhaled insulin and the factors that affect
their willingness to pay (WTP) are unknown. OBJECTIVES: To
determine (1) the relationship of patient satisfaction with current
insulin therapy and demographic factors on WTP for inhaled
insulin, and (2) predictors of patients’ WTP for inhaled insulin.
METHODS: Exploratory cross-sectional study design using a
random sample of diabetic patients from a national database.
Data were collected using a mailed survey that focused on a
patient satisfaction, willingness to pay, and general patient infor-
mation. Patient satisfaction was measured the Patient Satisfac-
tion with Insulin Therapy (PSIT) scale. Data were analyzed using
SPSS v.15.0 with an a priori alpha of 0.05. Descriptive statistics,
Point-biserial and Pearson correlations, Chi-Square analyses,
and Linear and Logistic regression modeling were conducted.
RESULTS: One hundred twenty-eight patients responded.
Annual household income, type of diabetes, patient satisfaction
with current insulin therapy, gender, number of insulin injections
per day, and current cost of insulin therapy were found to have
a signiﬁcant relationship with WTP. Annual household income
and patient satisfaction predict patients’ WTP, X2 (9,
N = 114) = 27.45, p = 0.001.While, current cost of insulin
therapy and annual income were found to be signiﬁcant predic-
tors of how much patients were willing to pay for inhaled insulin,
R2 = 0.242, p < 0.05. CONCLUSIONS: Patients with higher
annual incomes and those who are dissatisﬁed with their current
insulin therapy are willing to pay for inhaled insulin. Also,
patients with higher annual income and higher current cost of
insulin therapy are willing to pay more for inhaled insulin.
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OBJECTIVES: To compare treatment satisfaction (TS) associ-
ated with insulin administration in type 2 diabetes subjects
treated with either insulin glargine based regimens or Neutral
Protamine Hagedorn (NPH) insulin based regimens for at
least 6 months. METHODS: As part of a comparative, non-
interventional, multi-centre, cross-sectional study in a primary
care setting in Germany, patients with insulin-dependent type 2
diabetes completed the Insulin Treatment Experience Question-
naire (ITEQ), a new condition-speciﬁc instrument assessing TS,
and the Diabetes Treatment Satisfaction Questionnaire (DTSQs).
The ITEQ contained 28 items among seven subscales (leisure
activities, psychological barriers, handling, diabetes control,
dependence, weight control, sleep); forming an ITEQ total score
transformed as 0 to 100, with 100 indicates high treatment
satisfaction. To examine differences between the two treatment
groups Mann-Whitney U tests were used. Multivariate linear
regression models were performed to determine differences
between treatment groups, controlling for sociodemographic and
diabetes-related characteristics, respectively. RESULTS: Overall,
1858 individuals were enrolled in the study, and TS analyses were
conducted with data from the 1,602 per protocol patients (982
insulin glargine and 620 NPH insulin). Demographic data of
patients receiving either insulin glargine or NPH insulin were
similar. DTSQs satisfaction score, ITEQ subscales and ITEQ
total score differed between therapy regimens and were signiﬁ-
cantly higher in the insulin glargine group (DTSQs: 29.9  5.5
vs. 29.2  5.7, p = 0.01; ITEQ total score: 71.5  13.1 vs.
67.6  13.9, p < 0.001). Results of the regression models indi-
cate that differences between the groups were stable after adjust-
ment. CONCLUSIONS: Our results indicate that insulin glargine
was associated with signiﬁcant higher treatment satisfaction
compared to NPH insulin among patients with type 2 diabetes.
The results suggest that the use of insulin glargine provide an
additional treatment beneﬁt for type 2 patients with insulin
dependent diabetes mellitus.
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OBJECTIVES: 1) To compare means of calories burnt by exer-
cise, compliance, eating behavior score, diabetes knowledge,
BMI and Fasting Blood Glucose (FBG) between gender control-
ling for age; 2) To ﬁnd correlations between calories burnt by
exercise, compliance, eating behavior score, diabetes knowledge,
age, BMI and FBG; 3) To estimate Hierarchical Stepwise
Multiple Regression Analysis (MRA) model to predict FBG.
METHODS: A cross-sectional deductive survey by telephone
interviewing and accessing clinical data were employed to inves-
tigate relationship between health behavior factors namely—
calories burnt by exercise, compliance, eating behavior score,
demographic data and FBG of 200 type 2 diabetes patients at
Saraburi Hospital 2008, randomly generated by computer.
RESULTS: Total sample size of 200 (100%) diabetes patients,
mostly 138 (69.00%) were female, 62 (31.00%) were male with
average age 59.34  11.99 years, average BMI 26.79  2.50,
average calories burnt per week 2777.24  2420.89, average
compliance score 12.37  7.13, and average FBG 161.25 
54.10. Cronbach’s Alpha coefﬁcient of Sorofman’s Compliance
scale for constructs “right time” and “right amount” were
0.8157, and 0.8526 respectively and Auamnoy Eating Behavior
Scale was 0.7915. ANCOVA conﬁrmed that FBG, compliance,
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